1. ReportLinker Data
  2. Life Sciences
  3. Pharmaceutical
  4. Pharmaceutical Imports
  5. Import of Penicillins or…

Import of penicillins or streptomycins not in dosage forms to Viet Nam climbs in 2016

According to statistics announced by United Nations Statistical Office, pharmaceutical import strongly grew by 262.42% compared with the same time an year ago. It shows the all-time maximum since 2000 as the indicator greatly rose from 3 219 383 US Dollar to 11 667 826 US Dollar, as it follows the tendency of the previous year when it climbed by 280.35%. The overall changes for the prior 17 years hit an increase of 6 346.31%. As well as it has had a 0.73 percent CAGR during the last 5 years with a marginal overall rise since the 2000. It averaged 1 723 903.47 US Dollar from 2000 to 2016 and it reached its minimum of 181 000 US Dollar in 2000.

Import of penicillins or streptomycins not in dosage forms to Viet Nam climbs in 2016
Date US Dollar Variation
2016 11 667 826.00 262.42
2015 3 219 383.00 280.35
2014 846 435.00 83.25
2013 461 908.00 -39.29
2012 760 815.00 -33.53
2011 1 144 595.00 15.17
2010 993 860.00 -35.97
2009 1 552 117.00 149.06
2008 623 179.00 -56.94
2007 1 447 196.00 -16.51

Related Statistics

Pharmaceutical Imports in other Countries

Main Pharmaceutical Indicators

  • Pharmaceutical Imports

  • Pharmaceutical Exports

  • Medicine Use

    Use of medicines, usually meadured in in defined daily dosis (DDD) per day. The DDD consists of the assumed average maintenance dose per day for a drug used for its main indication in adults. Based on: World Health Organization.

  • Pharmaceutical Production

    Manufacture of basic pharmaceutical products and pharmaceutical preparations in million units of national currency or in volume index of production.

  • Pharmacist Density

  • Spending On Medicines

    Measures total value of spending on prescription medicines and insulins by retail pharmacies, hospitals, and other institutional pharmacies at invoice prices.

  • Re-Imbursed Pharmaceutical

    Share of re-imbursed medication in the pharmaceutical market, usually expressed in percentage of medication sales or in value of reimbursements (thousands or millions of national currency). It can be measured separately for generic medication and brand-name medication, or for the whole market. Based on: Organisation for Economic Co-operation and Development.

  • Pharmaceutical Registrations

  • Pharmaceutical Revenue

    Revenue of pharmaceutical industry. The latter is comprised of companies engaged in researching, developing, manufacturing and distributing drugs for human or veterinary use. Based on: United States Department of Commerce.

  • Drug Store Retail Sales